AB
The startup has developed a molecular diagnostics platform that detects circulating tumor cells and specific biomarkers from blood samples, which are often missed by traditional imaging techniques. This technology provides oncologists with critical insights for early cancer detection, enhancing patient care and treatment outcomes.
Updated 2 months ago
Funding
$7.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a molecular diagnostics platform that detects circulating tumor cells and specific biomarkers from blood samples, which are often missed by traditional imaging techniques. This technology provides oncologists with critical insights for early cancer detection, enhancing patient care and treatment outcomes.